Duchenne muscular dystrophy (DMD) is a fatal disorder affecting approximately 1 in 3500 live born males, characterized by progressive muscle weakness. Several different strategies are being investigated in developing a cure for this disorder. Until a cure is found, therapeutic and supportive care is
โฆ LIBER โฆ
Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy
โ Scribed by Dominic J. Wells
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 216 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0142-4319
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Therapeutics in Duchenne muscular dystro
โ
Strober, Jonathan B.
๐
Article
๐
2006
๐
American Society for Experimental NeuroTherapeutic
๐
English
โ 169 KB
Inefficient dystrophin expression after
โ
Peter B. Kang; Hart G.W. Lidov; Alexander J. White; Matthew Mitchell; Anuradha B
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 296 KB
Restoration of half the normal dystrophi
โ
Hoop, R. C. ;Russo, L. S. ;Riconda, D. L. ;Schwartz, L. S. ;Hoffman, E. P.
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 443 KB
๐ 2 views
Deficiency of brain synaptic dystrophin
โ
Dr Tae-Wan Kim; Kuo Wu; Ira B. Black
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 380 KB
Dystrophin and the integrity of the sarc
โ
C. J. Duncan
๐
Article
๐
1989
๐
Springer
๐
English
โ 376 KB
Tenascin-C expression in dystrophin-rela
โ
Daniel L. Settles; Robert A. Cihak; Harold P. Erickson
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 857 KB
The mdx mouse has a mutated dystrophin gene and is used as a model for the study of Duchenne muscular dystrophy (DMD). We investigated whether regenerating mdx skeletal muscle contains the extracellular matrix protein tenascin-C (TN-C), which is expressed in wound healing and nerve regeneration. Pri